Successful Treatment of Infective Panniculitis With Daptomycin in a Pregnant, Morbidly Obese Patient

Annals of Pharmacotherapy

Volumn 48, Issue 5, 2014, Pages 652-655

  Klibanov, Olga M ^a   Vickery, Stephen ^b   Nortey, Cynthia ^c  

^a WINGATE UNIVERSITY   (United States)

^b Appalachian College of Pharmacy   (United States)

^c Matthews Infectious Disease Specialists   (United States)

Author keywords

cellulitis; daptomycin; obesity; panniculitis; pregnancy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; DAPTOMYCIN; SULTAMICILLIN;

ADULT; ARTICLE; BLOOD CULTURE; BODY WEIGHT; CASE REPORT; CELLULITIS; DIABETES MELLITUS; DRUG EXPOSURE; ERYTHEMA; FEMALE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBID OBESITY; PANNICULITIS; PANNUS; PREGNANT WOMAN; PRIORITY JOURNAL; PRURITUS; SKIN INFECTION; SOFT TISSUE INFECTION;

CELLULITIS; DAPTOMYCIN; OBESITY; PANNICULITIS; PREGNANCY;

ADULT; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; FEMALE; HUMANS; OBESITY, MORBID; PANNICULITIS; PREGNANCY;

EID: 84898684560     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028014523731     Document Type: Article

References (11)

1. Katz ME,Heiken JP,Glazer HS,Lee JKT.Intraabdominal panniculitis: clinical, radiographic, and CT features.AJR Am J Roentgenol. 1985;145:293-296.
2. Delgado-Jimenez Y,Fraga J,Garcia-Diez A.Infective panniculitis.Dermatol Clin. 2008;26:471-480.
3. Patterson JW,Brown PC,Broecker AH.Infection-induced panniculitis.J Cutan Pathol. 1989;16:183-193.
4. Cubicin (daptomycin) [package insert]. Lexington, MA: Cubist Pharmaceuticals; 2013:.
5. Liu C,Bayer A,Cosgrove SE, et al.Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Clin Infect Dis. 2011;52:1-38.
6. Dvorchik BH,Damphousse D.The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects.J Clin Pharmacol. 2005;45:48-56.
7. Pai MP,Norenberg JP,Anderson T, et al.Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin.Antimicrob Agents Chemother. 2007;51:2741-2747.
8. Dawes M,Chowienczyk PJ.Pharmacokinetics in pregnancy.Best Pract Res Clin Obstet Gynaecol. 2001;15:819-826.
9. Cunha BA,Hamid N,Kessler H,Parchuri S.Daptomycin cure after cefazolin treatment failure of methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line.Heart Lung. 2005;34:442-447.
10. Shea K,Hilburger E,Baroco A,Oldfield E.Successful treatment of vancomycin-resistant Enterococcus faecium pyelonephritis with daptomycin during pregnancy.Ann Pharmacother. 2008;42:722-725.
11. Stroup JS,Wagner J,Badzinski T.Use of daptomycin in a pregnant patient with Staphylococcus aureus endocarditis.Ann Pharmacother. 2010;44:746-749.